Skip to content

Effect of Positive Expiratory Pressure on the Management of Chest Trauma

Effect of Positive Expiratory Pressure on the Management of Chest Trauma: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04548466
Enrollment
40
Registered
2020-09-14
Start date
2015-10-31
Completion date
2016-09-30
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Fracture

Brief summary

Chest trauma (CT) are a common problem in our environment caused mainly by traffic accidents and causal and domestic accidents among the elderly population. CTs, in some situations, can lead to sequelae such as fibrothorax secondary to hemothorax and / or empyema and residual chronic pain. Clinical regulations and guidelines recommend a guideline for chest physiotherapy (CP) for all patients with rib fractures, but there is little scientific evidence. It would be interesting to establish CP treatment protocols and describe the most appropriate techniques according to the type and stages of thoracic trauma consolidation. Objective: To evaluate the effect of Positive Expiratory Pressure (PEP) breathing added to conventional CP in terms of aid secretion clearance, pain control, pleuropulmonary radiological abnormalities, restoration of lung function, and admission days in the immediate phase of the CT.

Detailed description

After acceptance to participate in the study, patients will be computerized randomized into 2 groups: * PEP group: positive expiratory pressure breathing. * CONTROL group: conventional CP treatment without positive pressure brething. The period between day 0 and 20 days post-trauma is considered an immediate phase of CT. Once admitted, an initial evaluation by the doctor will be performed, and pleuro-pulmonary complications, the presence of respiratory failure, and pain control will be evaluated. The chest physiotherapist will perform a clinical and secretion assessment using the Seva test and a dynamic costal examination. The medical treatment of pain control will begin, and the treatment of CP will begin, where it will be randomized in 2 groups: 1- PEP group: positive expiratory pressure breathing with the help of a PEP bottle device. 2-CONTROL group: conventional CP treatment without positive pressure breathing will be daily FR sessions, on weekdays. Upon admission, hospital discharge and post-discharge, radiological checks (simple radiography) will be performed and forced vital capacity will be measured with forced spirometry.

Interventions

Sponsors

Hospital de Granollers
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 88 Years
Healthy volunteers
No

Inclusion criteria

* Chest trauma with three or more rib fractures with or without hemopneumothorax * Failure to meet any

Design outcomes

Primary

MeasureTime frameDescription
Aid secretion clearance1 monthTo determine if PEP bottle improves the secretion clearance

Secondary

MeasureTime frameDescription
Resolution of pleural lesions1 monthTo analysed if PEP bottle allows faster resolution of pleural lesions
Improve lung function1 monthTo determine if PEP bottle improves lung function tests
Reduce hospital stay1 monthTo assess if PEP bottle decreased hospital stay

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026